3D Systems Corporation Class Action Lawsuit - DDD
Case Summary
Investors who suffered a loss and would like to learn more, click here to contact us.
The 3D Systems class action lawsuit seeks to represent purchasers or acquirers of 3D Systems Corporation (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the “Class Period”). Captioned Herbermann v. 3D Systems Corporation, No. 25-cv-00734 (D. Del.), the 3D Systems class action lawsuit charges 3D Systems and certain of 3D Systems’ top executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the 3D Systems class action lawsuit, please provide your information in the form on this page. You can also contact attorney J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. Lead plaintiff motions for the 3D Systems class action lawsuit must be filed with the court no later than August 12, 2025.
CASE ALLEGATIONS: 3D Systems provides 3D printing and digital manufacturing solutions.
The 3D Systems class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) 3D Systems had understated the impact of weakened customer spending on 3D Systems’ business, while overstating its resilience in challenging industry conditions; and (ii) in addition, the updated milestone criteria in 3D Systems’ partnership with United Therapeutics Corporation would negatively impact 3D Systems’ Regenerative Medicine Program revenue.
The 3D Systems class action lawsuit further alleges that on March 26, 2025, 3D Systems announced its financial results for the fourth quarter and full-year 2024, reporting, among other things: (i) fourth quarter non-GAAP earnings-per-share (“EPS”) of -$0.19, missing consensus estimates by $0.08 per share, and sales revenue of $111 million, representing a -3.4% year-over-year decline and missing consensus estimates by $4.17 million; (ii) full-year sales of $440.1 million, a decrease of 10% compared to the prior year, driven by “lower hardware systems sales due to macroeconomic factors that are negatively impacting demand”; and (iii) a “$9 million revenue reduction in Q4 driven by a change in accounting estimates for [3D Systems’] Regenerative Medicine program” “related to the now anticipated use of preclinical human decedent testing . . . which led to refinement of the milestone technical criteria.” On this news, the price of 3D Systems stock fell nearly 21%, according to the complaint.
Then, on May 12, 2025, the 3D Systems class action lawsuit further alleges that 3D Systems announced its financial results for the first quarter of 2025, reporting, among other things, revenue of $94.5 million, down 8% year-over-year and missing consensus estimates of $99.5 million; a net loss of $37 million, or $0.28 per share, more than doubling the $16 million loss reported in the first quarter of 2024; an adjusted loss of $0.21 per share, deeper than consensus estimates of a loss of $0.14 per share; and adjusted EBITDA of a loss of $23.9 million, deepening from a $20.1 million loss in the first quarter of 2024. According to the complaint, 3D Systems attributed its disappointing results, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. 3D Systems also announced that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty, the 3D Systems class action lawsuit further alleges. On this news, the price of 3D Systems stock fell more than 26%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired 3D Systems securities during the Class Period to seek appointment as lead plaintiff in the 3D Systems class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the 3D Systems class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the 3D Systems class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the 3D Systems class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig.